AlloVir logo
AlloVir ALVR
$ 0.54 -5.42%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

AlloVir Balance Sheet 2011-2024 | ALVR

Annual Balance Sheet AlloVir

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-62.7 M -70.7 M -172 M -114 M -49.3 M -22.2 M - - - - - - -

Long Term Debt

16.6 M 28.2 M 23.5 M - - - - - - - - - -

Long Term Debt Current

10.8 M 7.16 M 6.59 M 3.23 M - - - - - - - - -

Total Non Current Liabilities

- - - 5.46 M 182 M 52.2 M - - - - - - -

Total Current Liabilities

28.4 M 24.3 M 37.9 M 12.3 M - - - - - - - - -

Total Liabilities

45 M 52.6 M 61.3 M 17.8 M 191 M 55.9 M - - - - - - -

Deferred Revenue

- - - - - 2.66 M - - - - - - -

Retained Earnings

-656 M -466 M -297 M -125 M -55.3 M -31.5 M - - - - - - -

Total Assets

191 M 277 M 287 M 371 M 139 M 25.3 M - - - - - - -

Cash and Cash Equivalents

90.1 M 106 M 202 M 123 M - - - - - - - - -

Book Value

146 M 225 M 225 M 353 M -51.5 M -30.6 M - - - - - - -

Total Shareholders Equity

146 M 225 M 225 M 353 M -51.5 M - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet AlloVir

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- 8.34 M 16 M 16.6 M 19.9 M 23 M 25.6 M 28.2 M 19.8 M - 20.8 M 23.5 M 25.1 M 4.33 M 5.41 M 5.46 M 5.46 M 5.46 M 5.46 M 8.69 M 8.69 M 8.69 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

1.41 M 10.7 M 23.7 M 45 M 53 M 53.6 M 50.5 M 52.6 M 40.5 M - 39.4 M 61.3 M 49.2 M 25 M 20.9 M 17.8 M 17.8 M 17.8 M 17.8 M 17.8 M 17.8 M 17.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-697 M -693 M -686 M -656 M -596 M -552 M -507 M -466 M -428 M - -341 M -297 M -239 M -194 M -156 M -125 M -125 M -125 M -125 M -55.3 M -55.3 M -55.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

123 M 131 M 144 M 191 M 248 M 283 M 244 M 277 M 294 M - 231 M 287 M 317 M 328 M 351 M 371 M 371 M 371 M 371 M 139 M 139 M 139 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

117 M 105 M 86 M 90.1 M 95.6 M 197 M 116 M 106 M 124 M 71.1 M 100 M 202 M 243 M 225 M 169 M 123 M 123 M 123 M 123 M 61.1 M 61.1 M 61.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

121 M 120 M 120 M 146 M 195 M 229 M 194 M 225 M 253 M - 192 M 225 M 267 M 302 M 330 M 353 M 353 M 353 M 353 M 122 M 122 M 122 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

121 M 120 M 120 M 146 M 195 M 229 M 194 M 225 M 253 M 158 M 192 M 225 M 267 M 302 M 330 M 353 M 353 M 353 M 353 M -51.5 M -51.5 M -51.5 M -32.9 M -30.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency